Kimberly McColley
Physician Assistant · Bellevue, NENPI 1013067016
Payments from drug & device makers
Across 123 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$460
- Lilly USA, LLC$326
- Takeda Pharmaceuticals U.S.A., Inc.$190
- Pfizer$163
- Bayer$161
- AbbVie$147
- plus $724 from 21 others
What the payments were for
- Food & beverage$2,171100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $460 |
| Lilly USA, LLC | 22 | $326 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $190 |
| Pfizer | 8 | $163 |
| Bayer | 10 | $161 |
| AbbVie | 7 | $147 |
| Novo Nordisk | 7 | $121 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Amgen | 4 | $56 |
| Arbor Pharmaceuticals, Inc. | 2 | $42 |
| Exact Sciences | 3 | $40 |
| Azurity Pharmaceuticals, Inc. | 2 | $39 |
| Gilead | 1 | $24 |
| Acella Pharmaceuticals, LLC | 1 | $21 |
| Merck | 1 | $20 |
| Eisai Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Tolmar, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Novartis | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
| Antares Pharma, Inc. | 1 | $11 |
How this compares
$2,171 in reported general payments places this provider in the 80th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 12 | $538 |
| Levocetirizine Dihydrochloride | 17 | $347 |
| Montelukast Sodium | 20 | $287 |
| Rosuvastatin Calcium | 14 | $232 |
| Tamsulosin Hcl | 15 | $182 |
| Omeprazole | 17 | $161 |
| Hydrochlorothiazide | 14 | $52 |
| Azithromycin | 11 | $50 |
| Atorvastatin Calcium | 15 | $49 |
| Alendronate Sodium | 14 | $48 |
| Baclofen | 11 | $29 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Bellevue
- Skyler JeszBellevue$6K
- Kimberly GatesOmaha$109K
- Kandice DoleshOmaha$106K
- Ronda FoleyElkhorn$64K
- Kathryn KestiOmaha$34K
- Sarah GretemanOmaha$24K
- Joel JasaGrand Island$18K
- Christopher BeasleyOmaha$15K
- Laura TvrdyLincoln$13K
- Courtney MaresLincoln$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.